AlphaYouRP
Schedule 13G filing
RainForest Partners, LLC disclosed a 10% stake in GT Biopharma, Inc. (GTBP)
RainForest Partners, LLC reported owning 10% of GT Biopharma, Inc. (GTBP) (180,258 shares) in a Schedule 13G filed Sep 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.